Study of Biological Determinants of Bleeding Postpartum
HPP-IPF
1 other identifier
observational
3,599
1 country
1
Brief Summary
At the entry of the delivery room, a standard blood analysis will be performed (Blood count, PT, aPTT, Fibrinogen, and D-Dimer) for each women (if they are agree), according to the center's practices. The percentage of the immature platelets is a an additional parameter on the hemogram. The clinical assessments (recorded in medical records) and biological values will be used to determine if there is a correlation between these data and the occurrence of postpartum hemorrhage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 26, 2016
CompletedFirst Posted
Study publicly available on registry
August 31, 2016
CompletedAugust 31, 2016
August 1, 2016
3.5 years
August 26, 2016
August 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postpartum Hemorrhage
Volume of blood loss up to 24 hours after delivery and / or weight compresses collected at delivery, and / or diagnosis of the clinician
Percentage of immature platelets
Percentage of immature platelets just before the entry in the birth room
Eligibility Criteria
Woman giving birth in a maternity of Finistère (France)
You may qualify if:
- Woman giving birth in a maternity of Finistère
You may not qualify if:
- Refuse to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de BREST
Brest, France
Biospecimen
PLASMA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
PAN-PETESCH Brigitte, Dr.
CHRU de BREST
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2016
First Posted
August 31, 2016
Study Start
November 1, 2011
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
August 31, 2016
Record last verified: 2016-08